Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex
- PMID: 14559787
Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex
Abstract
To search for potential molecular targets for development of novel anticancer drugs, we have been analyzing expression profiles of clinical samples from cancer patients, using a genome-wide cDNA microarray. In experiments with colon cancer cells, the gene encoding fibroblast growth factor 18 (FGF18) was among those that showed elevated expression. The promoter region of this gene was found to contain putative Tcf4-binding motifs; moreover a reporter-gene assay using luciferase activity as a marker and an electromobility shift assay indicated that FGF18 is a downstream transcription target in the beta-catenin/Tcf4 pathway. We showed that exogenous FGF18 promoted growth of NIH3T3 cells in an autocrine manner and that transfection of FGF18 short interfering RNAs suppressed growth of colon cancer cells in culture. Our results indicate that FGF18 is activated in colon cancers as a direct downstream target of the Wnt signaling pathway and that it might represent a marker for early diagnosis and a molecular target for treatment of this life-threatening tumor.
Similar articles
-
Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.Cancer Res. 2002 Oct 15;62(20):5651-6. Cancer Res. 2002. PMID: 12384519
-
Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.Cancer Res. 2001 Nov 1;61(21):7722-6. Cancer Res. 2001. PMID: 11691783
-
Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.Cancer Res. 2000 Dec 1;60(23):6683-7. Cancer Res. 2000. PMID: 11118053
-
Beta-catenin and the morphogenesis of colorectal cancer.Virchows Arch. 2002 Jul;441(1):1-11. doi: 10.1007/s00428-002-0642-9. Epub 2002 Apr 27. Virchows Arch. 2002. PMID: 12111194 Review.
-
Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling.Expert Rev Mol Diagn. 2002 Nov;2(6):565-75. doi: 10.1586/14737159.2.6.565. Expert Rev Mol Diagn. 2002. PMID: 12465453 Review.
Cited by
-
Enhancement of Migration and Invasion of Gastric Cancer Cells by IQGAP3.Biomolecules. 2020 Aug 17;10(8):1194. doi: 10.3390/biom10081194. Biomolecules. 2020. PMID: 32824461 Free PMC article.
-
Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas.Cancer Sci. 2005 Aug;96(8):498-506. doi: 10.1111/j.1349-7006.2005.00073.x. Cancer Sci. 2005. PMID: 16108831 Free PMC article.
-
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group.Clin Cancer Res. 2009 Mar 1;15(5):1770-8. doi: 10.1158/1078-0432.CCR-08-1030. Epub 2009 Feb 10. Clin Cancer Res. 2009. PMID: 19208794 Free PMC article.
-
FGF18 as a potential biomarker in serous and mucinous ovarian tumors.Tumour Biol. 2016 Mar;37(3):3173-83. doi: 10.1007/s13277-015-4129-0. Epub 2015 Oct 2. Tumour Biol. 2016. PMID: 26427667
-
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer.Cancer Res. 2013 Mar 15;73(6):2003-13. doi: 10.1158/0008-5472.CAN-12-3159. Epub 2013 Jan 14. Cancer Res. 2013. PMID: 23319804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous